Volume 149, Issue 1, Pages (March 2000)

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study Anna Lautamäki,

Hormone Replacement Therapy in Postmenopausal Women: Urinary N-Telopeptide of Type I Collagen Monitors Therapeutic Effect and Predicts Response of Bone.

Copyright © 2015 by the American Osteopathic Association.

Volume 77, Issue 5, Pages (March 2010)

Effects of long-term estrogen replacement therapy on articular cartilage IGFBP-2, IGFBP-3, collagen and proteoglycan levels in ovariectomized cynomolgus.

Volume 64, Pages e1-e3 (January 2017)

Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women Päivi Polo-Kantola,

Fig. 1. Serum levels of IGF-I vs

Héctor F Escobar-Morreale, M. D. , Ph. D

K. -M. Kaukonen, R. Linko, H. Herwald, L. Lindbom, E. Ruokonen, T

Acne: The Role of Medical Nutrition Therapy

Diagnostic Options for Assessment of Postmenopausal Bleeding

Volume 24, Issue 2, Pages (June 2017)

L. Aghajanova, L.C. Giudice Reproductive BioMedicine Online

Volume 11, Issue 6, Pages (June 2010)

Ophthalmologic findings in children with asthma receiving inhaled budesonide Anna Pelkonen, MD, PhD, Osmo Kari, MD, PhD, Olof Selroos, MD, PhD, Kurt Nikander,

Anne K. Berfield, Dennis L. Andress, Christine K. Abrass

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives George Mastorakos,

Expression of the insulin-like growth factor and insulin systems in the luteinizing macaque ovarian follicle Rebecca S. Brogan, Ph.D., Scott Mix, Muraly.

A. Mirakhur, M.J. Gallagher, M.J. Ledson, C.A. Hart, M.J. Walshaw

Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy Salvatore Caruso,

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome

Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone.

Anne K. Berfield, Dennis L. Andress, Christine K. Abrass

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome Kelly Stamets,

Autoradiographic mapping and characterization of insulin-like growth factor-I receptor binding in human greater saphenous vein Anton N. Sidawy, MD, Fares.

Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth.

Comparison of the Cardiovascular Effects of Tamsulosin Oral Controlled Absorption System (OCAS®) and Alfuzosin Prolonged Release (XL) Martin C. Michel,

The effect of hysteroscopic polypectomy on the concentrations of endometrial implantation factors in uterine flushings J Ben-Nagi, J Miell, J Yazbek,

Stephanie D. Gan, MD, Sarah H

Venous endothelial function in postmenopausal women who are receiving long-term estrogen and progestagen therapy Concepción Ceballos, Constantino Ribes,

Electrical Stimulation Therapy Increases Rate of Healing of Pressure Ulcers in Community-Dwelling People With Spinal Cord Injury Pamela E. Houghton,

Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:

Volume 77, Issue 5, Pages (March 2010)

Effects of long-term estrogen replacement therapy on articular cartilage IGFBP-2, IGFBP-3, collagen and proteoglycan levels in ovariectomized cynomolgus.

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

A new era in phosphate binder therapy: What are the options?

Recommendations for the management of patients with homozygous familial hypercholesterolaemia: Overview of a new European Atherosclerosis Society consensus.

Community-acquired pneumonia in adults

Effect of patient sex on general anaesthesia and recovery

Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling Jeffrey G. Jacot, BS, Ibrahim Abdullah,

Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women Päivi Polo-Kantola,

Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients Denis Fouque, Susy C. Peng, Eshan Shamir, Joel.

Insulin-like Growth Factors (IGF) and IGF-Binding Proteins Bound to Vitronectin Enhance Keratinocyte Protein Synthesis and Migration Carolyn Hyde, Brett.

Insulin-like growth factor-l and risk of breast cancer

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation Abel Suárez-Fueyo, PhD, Tania.

Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo.

Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial

ROGER S. MAZZE, Ph.D., CHRISTOPHER L. KROGH, M.D.

Ettore Cicinelli, M. D. , Louis J Ignarro, M. D. , Pietro Galantino, M

Change in LBM (%)‏ LD CD LD CD LD CD

Homeostasis model assessment of insulin resistance (HOMA-IR) correlates strongly with serum adiponectin (ADPN), insulin-like growth factor I (IGF-I), and.

It's not over till the last glomerulus forms

Volume 57, Issue 6, Pages (June 2000)

Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in.

A Randomized, Double-Blind, Placebo-controlled Study of Growth Hormone in the Treatment of Fibromyalgia 1 Robert M Bennett, Sharon C Clark, Jacqueline.

Naloxone decreases insulin secretion in hyperinsulinemic postmenopausal women and may positively affect hormone replacement therapy Francesco Cucinelli,

Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women Hong Zang, M.D., Kjell Carlström,

Effects of patch or gel estrogen therapies on auditory brainstem response in surgically postmenopausal women: a prospective, randomized study Salvatore.

HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal.

Tofacitinib therapy for children with severe alopecia areata

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone.

George Christodoulakos, M. D. , Irene Lambrinoudaki, M. D

Comparison of the Cardiovascular Effects of Tamsulosin Oral Controlled Absorption System (OCAS®) and Alfuzosin Prolonged Release (XL) Martin C. Michel,

Volume 4, Issue 3, Pages (March 2018)

Scrambler Therapy May Relieve Chronic Neuropathic Pain More Effectively Than Guideline-Based Drug Management: Results of a Pilot, Randomized, Controlled.

Estrogen improves endothelial function

Volume 56, Issue 6, Pages (December 1999)

Presentation transcript:

Volume 149, Issue 1, Pages 157-162 (March 2000) Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels Marita Paassilta, Anna Karjalainen, Kari Kervinen, Markku J Savolainen, Jorma Heikkinen, Ann-Christine Bäckström, Y.Antero Kesäniemi Atherosclerosis Volume 149, Issue 1, Pages 157-162 (March 2000) DOI: 10.1016/S0021-9150(99)00318-4

Fig. 1 Plasma levels of Lp(a) (Panel A), IGF-I (Panel B) and IGFBP-1 (Panel C) during the 6-month ERT in postmenopausal women, presented in percentage values (S.E.M.) from the baseline level. Closed squares represent the oral treatment group (n=35) (P-values for the overall difference from the baseline values indicated by ANOVA), whereas open squares represent the transdermal treatment group (n=38) (NS by ANOVA). Atherosclerosis 2000 149, 157-162DOI: (10.1016/S0021-9150(99)00318-4)

Fig. 2 Spearman correlation between the absolute changes (baseline to 6 months of ERT) in plasma Lp(a) levels and IGFBP-1 levels during the oral ERT (n=35). Atherosclerosis 2000 149, 157-162DOI: (10.1016/S0021-9150(99)00318-4)